You are viewing the site in preview mode
Skip to main content
| |
Mean scores ± SD of women with FGM/C
|
Mean scores ± SD of women without FGM/C
|
|---|
|
All (n = 124)
|
I (n = 9)
|
II (n = 41)
|
III (n = 74)
|
With PFD2
|
|---|
|
PISQ-IR1
| | | | | |
|
SA-AO1
|
3.3 ± 1.1 (n = 85)
|
3.2 ± 0.9 (n = 8)
|
3.5 ± 0.9 (n = 27)
|
3.3 ± 1.2 (n = 50)
|
3.4 ± 0.8
|
|
SA-PR1
|
3.4 ± 0.6 (n = 84)
|
3.8 ± 0.3 (n = 8)
|
3.4 ± 0.7 (n = 27)
|
3.4 ± 0.7 (n = 49)
|
3.2 ± 0.7
|
|
SA-CS1
|
4.5 ± 0.8 (n = 84)
|
4.8 ± 0.4 (n = 8)
|
4.5 ± 1.1 (n = 27)
|
4.5 ± 0.7 (n = 49)
|
4.4 ± 0.7
|
|
SA-CI1
|
3.8 ± 0.5 (n = 82)
|
3.9 ± 0.2 (n = 8)
|
3.7 ± 0.6 (n = 26)
|
3.8 ± 0.5 (n = 48)
|
3.0 ± 0.9
|
|
SA-D1
|
2.9 ± 1.0 (n = 83)
|
2.8 ± 1.2 (n = 8)
|
3.0 ± 1.0 (n = 26)
|
2.9 ± 1.0 (n = 49)
|
3.0 ± 0.9
|
|
SA-GQ1
|
3.9 ± 1.1 (n = 80)
|
3.5 ± 1.3 (n = 8)
|
3.7 ± 1.2 (n = 26)
|
4.1 ± 1.0 (n = 46)
|
3.0 ± 1.1
|
|
NSA-CS1
|
1.5 ± 0.7 (n = 37)
|
1.0 ± 0.0 (n = 1)
|
1.4 ± 0.5 (n = 13)
|
1.5 ± 0.8 (n = 23)
|
2.8 ± 1.0
|
|
NSA-PR1
|
2.6 ± 0.8 (n = 35)
|
2.5 ± 0.0 (n = 1)
|
2.6 ± 1.0 (n = 11)
|
2.6 ± 0.8 (n = 23)
|
2.2 ± 1.0
|
|
NSA-CI1
|
1.2 ± 0.6 (n = 36)
|
1.0 ± 0.0 (n = 1)
|
1.1 ± 0.3 (n = 13)
|
1.3 ± 0.7 (n = 22)
|
2.1 ± 0.1
|
|
NSA-GQ1
|
2.3 ± 1.2 (n = 37)
|
1.5 ± 0.0 (n = 1)
|
2.0 ± 1.2 (n = 13)
|
2.6 ± 1.2 (n = 23)
|
2.9 ± 1.2
|
- 1Pelvic organ prolapse Incontinence Sexual Questionnaire—IUGA Revised (PISQ-IR) for Sexually Active (SA) and Non-Sexually Active (NSA), Arousal and Orgasm (AO), Partner-Related impact on activity/inactivity (PR), Condition-Specific impact on activity/inactivity (CS), Condition-specific Impact on quality (CI), Desire (D), and Global Quality (GQ)
- 2Pelvic floor dysfunction (urinary incontinence and/or pelvic organ prolapse and/or fecal incontinence)
